These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 632195)

  • 1. Hair chewing associated with suspected hyperadrenocorticism in a dog.
    Chastain CB
    J Am Vet Med Assoc; 1978 Mar; 172(5):573-4. PubMed ID: 632195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
    Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM
    J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperadrenocorticism: treating dogs.
    Brown CG; Graves TK
    Compend Contin Educ Vet; 2007 Mar; 29(3):132-4, 136, 138 passim; quiz 144-5. PubMed ID: 17726933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS; Farver TB
    J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus, hyperadrenocorticism, and hypothyroidism in a dog.
    Hess RS; Ward CR
    J Am Anim Hosp Assoc; 1998; 34(3):204-7. PubMed ID: 9590447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems associated with medical therapy of canine hyperadrenocorticism.
    Nichols R
    Probl Vet Med; 1990 Dec; 2(4):551-6. PubMed ID: 2134073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined corneal lipid and calcium degeneration in a dog with hyperadrenocorticism: a case report.
    Laus JL; dos Santos C; Talieri IC; Oriá AP; Bechara GH
    Vet Ophthalmol; 2002 Mar; 5(1):61-4. PubMed ID: 11940251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comments on use of mitotane.
    Watson AD
    J Am Vet Med Assoc; 1995 Jan; 206(1):25. PubMed ID: 7744655
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane.
    Reine NJ
    Clin Tech Small Anim Pract; 2007 Feb; 22(1):18-25. PubMed ID: 17542193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
    Nelson RW; Feldman EC; Shinsako J
    Am J Vet Res; 1985 Jul; 46(7):1534-7. PubMed ID: 2992329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma camera imaging of bilateral adrenocortical hyperplasia and adrenal tumors in the dog.
    Mulnix JA; Van den Brom WE; Lubberink AA; de Bruijne JJ; Rijnberk A
    Am J Vet Res; 1976 Dec; 37(12):1467-71. PubMed ID: 999071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of non-selective adrenocorticolysis with mitotane or trilostane for the treatment of dogs with pituitary-dependent hyperadrenocorticism.
    Clemente M; De Andrés PJ; Arenas C; Melián C; Morales M; Pérez-Alenza MD
    Vet Rec; 2007 Dec; 161(24):805-9. PubMed ID: 18083978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
    Angles JM; Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perianal adenomas and hypertestosteronemia in a spayed bitch with pituitary-dependent hyperadrenocorticism.
    Dow SW; Olson PN; Rosychuk RA; Withrow SJ
    J Am Vet Med Assoc; 1988 May; 192(10):1439-41. PubMed ID: 2839445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary macroadenomas and macroadenocarcinomas in dogs treated with mitotane for pituitary-dependent hyperadrenocorticism: 13 cases (1981-1986).
    Nelson RW; Ihle SL; Feldman EC
    J Am Vet Med Assoc; 1989 Jun; 194(11):1612-7. PubMed ID: 2753785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of hyperadrenocorticism in the dog.
    Braddock JA
    Aust Vet J; 2003; 81(1-2):31-3. PubMed ID: 15084005
    [No Abstract]   [Full Text] [Related]  

  • 17. One-year follow-up evaluation of magnetic resonance imaging of the brain in dogs with pituitary-dependent hyperadrenocorticism.
    Bertoy EH; Feldman EC; Nelson RW; Dublin AB; Reid MH; Feldman MS
    J Am Vet Med Assoc; 1996 Apr; 208(8):1268-73. PubMed ID: 8635969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog.
    Park SM; Kim KB; Song WJ; Youn HY
    Vet Med Sci; 2021 Jul; 7(4):1150-1153. PubMed ID: 33755348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms.
    Kintzer PP; Peterson ME
    J Am Vet Med Assoc; 1994 Jul; 205(1):54-61. PubMed ID: 7928549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Old or new? A comparison of mitotane and trilostane for the management of hyperadrenocorticism.
    Griffies JD
    Compend Contin Educ Vet; 2013 May; 35(5):E3. PubMed ID: 23677783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.